14/11/2016 11:19:07

NeuroSearch found guilty of market manipulation in Supreme Court case

Related content
05 Dec - 
Update on NeuroSearch’s business status and future
17 Nov - 
NeuroSearch upgrades its guidance for 2017
31 Aug - 
NeuroSearch A/S – H1 report 2017
Related debate
07 Dec - 
drypkørt lidt flere, handles til ren cash, jeg tror sta..
06 Dec - 
Er enig med Malurt...Jeg ser ikke andre værdier end kon..
06 Dec - 
snart solgt én million aktier på to dage og kursen hold..

Announcement

14 November 2016

The Danish Supreme Court today upheld the Eastern High Court’s decision in a case in which the State Prosecutor for Serious Economic and International Crime had charged NeuroSearch with market manipulation contrary to the Danish Securities Trading Act and the Market Abuse Regulation. The company was further ordered to pay a fine of DKK 5 million.

The charge was brought following NeuroSearch’s announcement in February 2010 in which the company reported top-line results from a clinical phase III study on its drug candidate Huntexil®.

Chairman of the board of directors, Karin Garre, says in a comment:

"It is very regrettable that the Supreme Court has decided to uphold the High Court’s judgment considering that the High Court acquitted the company’s former CEO on the same count. NeuroSearch of course will respect the Supreme Court's ruling that the company is responsible for the announcement concerning the outcome of a clinical study in 2010 contained misleading signals about the market price so that it amounted to market manipulation. This does not reflect NeuroSearch’s view of the situation and that is why we decided to refer the matter to the Supreme Court. With this ruling, the company will work with a view to rapidly decide the future of the company.”

Following the Supreme Court judgment, the board of directors will now assess NeuroSearch’s future and provide the shareholders with the board’s recommendations on the steps to be taken.

The judgment does not affect the company’s expectations for the annual results in 2016.

Karin Garre                                                 Allan Andersen

Chairman of the Board                                CEO

Contact

Allan Andersen, CEO, telephone: +454016 3864.

About NeuroSearch

NeuroSearch A/S (NEUR) is listed on NASDAQ Copenhagen A/S.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
06 Dec
NEUR
om 3 måneder er kursen under 3, så god fornøjelse.
2
06 Dec
NEUR
Man behøver ikke komme med sure negative bemærkninger for at får kursen på Neuro ned.   Det kommer h..
1
06 Dec
NEUR
God ide 
1
06 Dec
NEUR
Ja, når der er optur på vej i en aktie, så er der nogen der ikke kom med på toget. De kommer så med ..
1
05 Dec
NEUR
uenig - den er overhovedet ikke attraktiv. 
1
05 Dec
NEUR
ja, 75 mio med fradrag af likvidationsomkostninger og renter. Selskabet har været til salg så længe,..
1

Dimensional Fund Advisors Ltd. : Form 8.3 - Tesco Plc - Ordinary shares

11/12/2017 10:25:28
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:   Dimensional Fund Advisors Ltd. ("Dimensional"), in its capacity ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Karyopharm Presents Positive Phase 1/2 Eltanexor Data at the American Society of Hematology 2017 Annual Meeting
2
Algeco Scotsman Announces Debt Package for Refinancing, Acquisition of Touax Solutions Modulaires SAS and Exercise of Put Option
3
Karyopharm Presents Positive Selinexor Data from the Phase 1b/2 STOMP Study at the American Society of Hematology 2017 Annual Meeting
4
Exclusive: Today, 9 December 2017, Artprice confirms that the acquisition of Da Vinci's Salvator Mundi involved geopolitical mediation, and that the Vatican Museums did indeed study the offer
5
Algeco Scotsman Announces Debt Package for Refinancing, Acquisition of Touax Solutions Modulaires SAS and Exercise of Put Option

Related stock quotes

NeuroSearch A/S 4.32 5.4% Stock price increasing

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
11 December 2017 20:56:35
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20171124.1 - EUROWEB5 - 2017-12-11 21:56:35 - 2017-12-11 20:56:35 - 1000 - Website: OKAY